Moos Gitte Knudsen
Gitte Moos Knudsen, Professor of neurobiology, chief consultant, Chairman of the Neurobiology Research Unit at the Copenhagen University Hospital Rigshospitalet, Director of Center for Experimental Medicine Neuropharmacology (NeuroPharm) and PI of the strategic alliance BrainDrugs.
I am a translational neurobiologist and clinical neurologist with an interest in advanced methodological developments that I subsequently apply in my research to address pertinent neurobiological and clinical issues. My scientific interests include blood-brain barrier transport, neurobiology of cerebral blood flow and metabolism and the neurobiology of cerebral neurotransmission with particular emphasis on molecular brain imaging. The research focus of The Center for Experimental Medicine Neuropharmacology (NeuroPharm) is to answer pertinent and basic questions regarding human brain disease mechanisms and predict brain responses to categories of neuromodulatory interventions as well as treatment efficacy. For this purpose, we use PET brain scanning to image brain receptors and receptor occupancy, and fMRI to evaluate drug effects on the brain hemodynamic response as well as the brain’s regional interactions, i.e., functional connectivity. The strategic alliance BrainDrugs started in 2019, based on a Lundbeck Foundation grant, and is a precision medicine alliance within brain disorders.
Published 382 Medline indexed scientific papers and 28 books/book chapters. GoogleScholar: >15,000 citations, H-index: 61. Web-of-Science: >11,000 citations, H-index: 52.
ResearcherID: C-1368-2013. ORCID-ID: orcid.org/0000-0003-1508-6866